Via: http://goo.gl/VSiY1m
Showing posts with label Indonesia. Show all posts
Showing posts with label Indonesia. Show all posts
Saturday, May 14, 2016
Tuesday, March 8, 2016
Injecting Drug Use, Sexual Risk, HIV Knowledge & Harm Reduction Uptake in a Large Prison in Bali, Indonesia
Purpose
The purpose of this paper is to describe HIV-related risk behavior and knowledge of HIV among inmates of Kerobokan prison Bali, Indonesia. Design/methodology/approach - A cross-sectional survey of inmates of using a structured questionnaire and sample framework to reflect narcotic use among inmates and the prison gender mix.
Findings
Among 230 inmates recruited to the study self-reported prevalence of injecting drug use was 7.4 percent (95 percent CI 4.0-10.8 percent). Respondents who participated in a prison based methadone treatment program were all still injecting drugs, these made up 13/17 of the IDU. In total, 47 percent (95 percent CIs 45-55 percent) of respondents who reported injecting also reported sharing needles within the last week. Sexual intercourse while in prison was reported by 3.0 percent (95 percent CI 0.82-5.26 percent) of study respondents. One-third of non-injectors were unaware of the preventative role of condom use. This study suggests that despite harm reduction initiatives within Kerobokan prison HIV risk behavior continues and there is a considerable lack of awareness of the importance of condom use in preventing HIV.
Research limitations/implications
The authors relied on self-reported risk behavior that may be subject to reporting bias. The sampling strategy may not reflect the true ratio inmates using or not using narcotics.
Practical implications
The current harm reduction approach, including methadone substitution treatment should be optimized within the Indonesian prison setting. Originality/value - This is the first study reporting HIV-related risk behavior from an Indonesian prison with an established methadone substitution program.
The purpose of this paper is to describe HIV-related risk behavior and knowledge of HIV among inmates of Kerobokan prison Bali, Indonesia. Design/methodology/approach - A cross-sectional survey of inmates of using a structured questionnaire and sample framework to reflect narcotic use among inmates and the prison gender mix.
Findings
Among 230 inmates recruited to the study self-reported prevalence of injecting drug use was 7.4 percent (95 percent CI 4.0-10.8 percent). Respondents who participated in a prison based methadone treatment program were all still injecting drugs, these made up 13/17 of the IDU. In total, 47 percent (95 percent CIs 45-55 percent) of respondents who reported injecting also reported sharing needles within the last week. Sexual intercourse while in prison was reported by 3.0 percent (95 percent CI 0.82-5.26 percent) of study respondents. One-third of non-injectors were unaware of the preventative role of condom use. This study suggests that despite harm reduction initiatives within Kerobokan prison HIV risk behavior continues and there is a considerable lack of awareness of the importance of condom use in preventing HIV.
Research limitations/implications
The authors relied on self-reported risk behavior that may be subject to reporting bias. The sampling strategy may not reflect the true ratio inmates using or not using narcotics.
Practical implications
The current harm reduction approach, including methadone substitution treatment should be optimized within the Indonesian prison setting. Originality/value - This is the first study reporting HIV-related risk behavior from an Indonesian prison with an established methadone substitution program.
Purchase full article at: http://goo.gl/aHFqiu
By: Sawitri AA1, Hartawan AA, Craine N, Sari AK, Septarini NW, Wirawan DN.
- 1Department of Community and Preventive Medicine, Udayana University Bali, Denpasar, Indonesia.
- Int J Prison Health. 2016 Mar 14;12(1):27-38. doi: 10.1108/IJPH-05-2014-0011.
More at: https://twitter.com/hiv insight
Saturday, February 20, 2016
Toxoplasma & Viral Antibodies among HIV Patients & Inmates in Central Java, Indonesia
In Indonesia, Toxoplasma and
its associations with blood-borne viruses have been poorly studied. In order to
study the association between anti-Toxoplasma antibodies and blood-borne viral
antibodies, blood samples from 497 participants (375 inmates from four prisons
in Central Java, Indonesia and 122 HIV patients at a Voluntary Counseling and
Testing Clinic in Surakarta, Indonesia) were tested for serological markers of
Toxoplasma, human immunodeficiency virus (HIV), hepatitis B virus (HBV),
hepatitis C virus (HCV), hepatitis D virus (HDV) and human T-lymphotropic virus
types I and II (HTLV-1/2).
Anti-Toxoplasma IgG and IgM positivity rates were 41.6% and 3.6%, respectively. One point two percent of participants was positive for both anti-Toxoplasma IgG and IgM antibodies. Sixteen point five percent, 11.3%, 2.6% and 2.8% of participants were positive for anti- Toxoplasma IgG combined with anti-HCV antibodies, anti-Toxoplasma IgG combined with anti-HIV antibodies, anti-Toxoplasma IgM combined with anti-HIV antibodes and anti-Toxoplasma IgG combined with both anti-HIV and anti-HCV antibodies, respectively. Anti-Toxoplasma IgM seropositivity was associated with anti-HIV (aOR = 4.3; 95% CI: 1.112-16.204, p = 0.034). Anti-Toxoplasma IgG antibodies were associated with anti-HCV (aOR = 2.8; 95% CI: 1.749-4.538, p < 0.001) and history of injection drug use (aOR = 3.1; 95% CI: 1.905-5.093, p < 0.001).
In conclusion, we recommend patients with HIV, HCV infection and injection drug users should be screened for Toxoplasma infection in Indonesia.
Anti-Toxoplasma IgG and IgM positivity rates were 41.6% and 3.6%, respectively. One point two percent of participants was positive for both anti-Toxoplasma IgG and IgM antibodies. Sixteen point five percent, 11.3%, 2.6% and 2.8% of participants were positive for anti- Toxoplasma IgG combined with anti-HCV antibodies, anti-Toxoplasma IgG combined with anti-HIV antibodies, anti-Toxoplasma IgM combined with anti-HIV antibodes and anti-Toxoplasma IgG combined with both anti-HIV and anti-HCV antibodies, respectively. Anti-Toxoplasma IgM seropositivity was associated with anti-HIV (aOR = 4.3; 95% CI: 1.112-16.204, p = 0.034). Anti-Toxoplasma IgG antibodies were associated with anti-HCV (aOR = 2.8; 95% CI: 1.749-4.538, p < 0.001) and history of injection drug use (aOR = 3.1; 95% CI: 1.905-5.093, p < 0.001).
In conclusion, we recommend patients with HIV, HCV infection and injection drug users should be screened for Toxoplasma infection in Indonesia.
Via: http://goo.gl/NRlZKA
By: Sari Y, Haryati S, Raharjo I, Prasetyo AA.
Southeast Asian J Trop Med Public Health. 2015 Nov;46(6):977-85.
More at: https://twitter.com/hiv insight
Sunday, February 14, 2016
Effect of HIV Prevention & Treatment Program on HIV & HCV Transmission & HIV Mortality at an Indonesian Narcotic Prison
Validated data regarding
HIV-transmission in prisons in developing countries is scarce. We examined
sexual and injecting drug use behavior and HIV and HCV transmission in an
Indonesian narcotic prison during the implementation of an HIV prevention and
treatment program during 2004-2007 when the Banceuy Narcotic Prison in
Indonesia conducted an HIV transmission prevention program to provide 1) HIV
education, 2) voluntary HIV testing and counseling, 3) condom supply, 4)
prevention of rape and sexual violence, 5) antiretroviral treatment for
HIV-positive prisoners and 6) methadone maintenance treatment.
During a first
survey that was conducted between 2007 and 2009, new prisoners entered Banceuy
Narcotics Prison were voluntary tested for HIV and HCV-infection after written
informed consent was obtained. Information regarding sexual and injecting risk
behavior and physical status were also recorded at admission to the prison.
Participants who tested negative for both HIV and HCV during the first survey
were included in a second survey conducted during 2008-2011.
During both
surveys, data on mortality among HIV-seropositive patients were also recorded.
All HIV-seropositive participants receive treatment for HIV. HIV/ AIDS-related
deaths decreased: 43% in 2006, 18% in 2007, 9% in 2008 and 0% in 2009. No HIV
and HCV seroconversion inside Banceuy Narcotic Prison were found after a median
of 23 months imprisonment (maximum follow-up: 38 months). Total of 484.8 person-years
observation was done. Participants reported HIV transmission risk-behavior in
Banceuy Prison during the second survey was low.
After implementation of HIV
prevention and treatment program, no new HIV or HCV cases were detected and
HIV-related mortality decreased.
Article via: http://goo.gl/0abLLk
By: Nelwan EJ, Indrati AK, Isa A, Triani N, Alam NN, Herlan MS, Husen W, Pohan HT, Alisjahbana B, Meheus A, Van Crevel R, van der Ven AJ.
Southeast Asian J Trop Med Public Health. 2015 Sep;46(5):880-91.
More at: https://twitter.com/hiv insight
Saturday, January 30, 2016
Impacts of Stigma on HIV Risk for Women Who Inject Drugs in Java: A Qualitative Study
Highlights
- Javanese women who inject drugs felt stigmatized by health professionals and others.
- This stigma contributed to feelings of shame.
- Drug use was hidden by avoiding those who do not inject and harm reduction services.
- Trust in their small group of injecting friends contributed to sharing needles.
Background
People who inject
drugs have experienced stigma around the world. Stigma has been found to have
negative consequences for individuals in relation to health-service use,
psychological wellbeing and physical health; and for populations in terms of
health inequalities. Indonesia has experienced a rapid growth in injecting drug
use and HIV and little is known about drivers of HIV risk among Indonesian
women who inject drugs. The purpose of this paper is to describe and consider
the multiple impacts of stigmatization of injecting drug use on injecting
behaviors among women who inject drugs in Java.
Methods
In-depth
interviews were conducted with 19 women who inject drugs in Java. Mean age was
25 years, all but one was employed or at college. The interviewers were
Indonesian women.
Results
Significant stigma
around women's drug use was reported from multiple sources in Java including
family, friends and health services, resulting in feelings of shame. To avoid
this stigma, most of the study participants hid their drug use. They lived away
from family and had few friends outside their drug-injecting circle, resulting
in isolation from mainstream society and harm-reduction services. Sharing of
injecting equipment was restricted to a small, closed circle of trusted friends,
thus limiting possible HIV transmission to a small number of injectors.
Conclusions
The stigmatization
of drug use, particularly of drug use by women, in Indonesia appears to have
contributed to significant shame, isolation from mainstream society and high
rates of sharing injecting equipment with a small group of trusted friends
(particularly the partner).
Purchase full article at:
By: Catherine Spoonera, , , Antonia Morita Iswari
Saktiawatib, , Elan Lazuardib, , Heather Wortha, ,Yanri Wijayanti Subrontob, , Retna Siwi Padmawatib,
a UNSW Australia, Sydney, NSW
2052, Australia
b Center for Tropical Medicine,
Faculty of Medicine, Gadjah Mada University, Bulaksumur, Yogyakarta 55281,
Indonesia
More at: https://twitter.com/hiv insight
Thursday, January 21, 2016
Cardiac Effects of Antiretroviral-Naïve versus Antiretroviral-Exposed HIV Infection in Children
Background
Cardiac
involvement in HIV infected children has been frequently reported, but whether
this is due to HIV infection itself or to antiretroviral treatment (ART) is
unknown.
Methods
This
cross sectional study involved 114 vertically-acquired HIV-infected (56
ART-naive, 58 ART-exposed) and 51 healthy children in Jakarta, Indonesia.
Echocardiography was performed to measure dimensions of the left ventricle (LV)
and systolic functions. We applied general linear modeling to evaluate the
associations between HIV infection/treatment status and cardiac parameters with
further adjustment for potential confounders or explanatory variables. Findings
are presented as (adjusted) mean differences between each of the two HIV groups
and healthy children, with 95% confidence intervals and p values.
Results
Compared
to healthy children, ART-naïve HIV-infected children did not show significant
differences in age-and-height adjusted cardiac dimensions apart from larger LV
internal diameter (difference 2.0 mm, 95%CI 0.2 to 3.7), whereas ART exposed
HIV infection showed thicker LV posterior walls (difference = 1.1 mm, 95%CI 0.5
to 1.6), larger LV internal diameter (difference = 1.7 mm, 95%CI 0.2 to 3.2)
and higher LV mass (difference = 14.0 g, 7.4 to 20.5). With respect to systolic
function, reduced LV ejection fraction was seen in both ART-naïve HIV infected
(adjusted difference = -6.7%, -11.4 to -2.0) and, to a lesser extent, in
ART-exposed HIV infected children (difference = -4.5%, -8.5 to -0.4).
Inflammation level seemed to be involved in most associations in ART-exposed
HIV-infected, but few, if any, for decreased function in the ART-naive ones,
whereas lower hemoglobin appeared to partially mediate chamber dilation in both
groups and reduced function, mainly in ART-exposed children.
Conclusions
ART-naive HIV infected children have a substantial
decrease in cardiac systolic function, whereas the ART-exposed have thicker
ventricular walls with larger internal diameter and higher mass, but less
functional impairment.
Below: Influence of potential explanatory variables on cardiac
structural estimates in ART-naive and ART-exposed HIV infected children. Note: LVPWd = left ventricular posterior wall thickness at
end-diastole; LVIDd = left ventricular internal diameter at end-diastole; LV
mass = left ventricular mass; RWT = relative wall thickness; Hb = hemoglobin
level; BP = systolic and diastolic blood pressure.
Below: Influence of potential explanatory variables on cardiac
functional estimates in ART-naive and ART-exposed HIV infected children. Note: EF = ejection fraction; FS = fractional shortening;
TAPSE = tricuspid annular plane systolic excursion; Hb = hemoglobin level; BP =
systolic and diastolic blood pressure.
Full article at: http://goo.gl/epfyuV
By:
Nikmah S. Idris, Nia Kurniati
Department of Child Health, Faculty of Medicine University
of Indonesia - Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia
Nikmah S. Idris, Diederick E. Grobbee, Cuno S. P. M.
Uiterwaal
Julius Global Health, Julius Centre for Health Sciences and
Primary Care, the University Medical Centre Utrecht, Utrecht, Netherlands
Nikmah S. Idris, Michael M. H. Cheung, David Burgner
Department of Pediatrics, University of Melbourne; Heart
Research Group, Murdoch Children's Research Institute, Royal Children's
Hospital, Parkville, Melbourne, Australia
More at: https://twitter.com/hiv insight
Wednesday, January 13, 2016
Testing the Woman Abuse Screening Tool to Identify Intimate Partner Violence in Indonesia
Intimate Partner Violence
(IPV) is a global public health problem. IPV prevalence in Indonesia has been
estimated to be less than 1%, based on reported cases. It is likely that IPV
prevalence is underreported in Indonesia, as it is in many other countries.
Screening for IPV has been found to increase IPV identification, but no
screening tools are in use in Indonesia.
The aim of this study was to test the
translated Woman Abuse Screening Tool (WAST) for detecting IPV in Indonesia.
The WAST was tested against a diagnostic interview by a trained psychologist on
240 women attending two Primary Health Centers in Jakarta. IPV prevalence and
the reliability, sensitivity, and specificity of the WAST were estimated.
Prevalence of IPV by diagnostic interview was 36.3%, much higher than published
estimates. The most common forms of IPV identified were psychological (85%) and
physical abuse (24%). Internal reliability of the WAST was high (α = .801).
A
WAST score of 13 (out of 24) is the recommended cutoff for identifying IPV, but
only 17% of the Indonesian sample scored 13 or higher. Test sensitivity of the
WAST with a cutoff score of 13 was only 41.9%, with a specificity of 96.8%.
With a cutoff score of 10, the sensitivity improved to 84.9%, while the
specificity decreased to 61.0%.
Use of the WAST with a cutoff score of 10
provides good sensitivity and reasonable specificity and would provide a
much-needed screening tool for use in Indonesia. Although a lower cutoff would
yield a greater proportion of false positives, most of the true cases would be
identified, increasing the possibility that women experiencing abuse would
receive needed assistance.
IPV Help-Seeking Behavior (N = 240).
| Would report IPV | |
| Would visit a PHC | 26 (10.8%) |
| Would visit an Emergency Response Unit | 3 (1.3%) |
| Would visit to service provider | 20 (8.3%) |
| Would report to a policewoman’s desk | 24 (10.0%) |
| Would call a hotline service | 3 (1.3%) |
| Would report, but did not specify to whom | 7 (2.9%) |
| Total | 83 (34.6%) |
| Would not report | |
| Would talk to family and friends | 106 (44.2%) |
| Would remain quiet | 32 (13.3%) |
| Would leave husband | 4 (1.7%) |
| Would practice self defense | 6 (2.5%) |
| Total | 148 (61.7%) |
| Did not respond to question | 9 (3.7%) |
Note. IPV = Intimate Partner Violence; PHC = Primary Health Centers.
Full article at: http://goo.gl/GDrHkM
By: Livia
Iskandar, MSc, DrPH,1 Kathryn L.
Braun, DrPH,1 and Alan R.
Katz, MD, MPH1
1University of Hawaii, Honolulu, USA
Corresponding Author: Kathryn L. Braun, Office of Public Health
Studies, John A. Burns School of Medicine, University of Hawaii, 1960 East-West
Road, Biomed D-204, Honolulu, HI 96822, USA. Email: ude.iiawah@nuarbk
More at: https://twitter.com/hiv
insight
Saturday, December 12, 2015
Women with HIV In Indonesia: Are They Bridging a Concentrated Epidemic to the Wider Community?
Background
Male injecting drug
users drove the onset of the HIV epidemic in Indonesia but over time more women
have been diagnosed. We examined the relative proportion of female patients in
an HIV cohort and characterized their probable transmission route and reproductive
profile.
Designs
Prospective cohort study
in a referral hospital in West Java.
Methods
Interviews with
standardized questionnaires, physical and laboratory examinations were done for
2622 individuals enrolled in HIV care between 2007 and 2012. The proportion of
women in this cohort was compared with national estimates. The general
characteristics of HIV-infected women and men as well as the sexual and
reproductive health of HIV-infected women were described.
Results
The proportion of female
patients enrolled in HIV care increased from 22.2 % in 2007 to 38.3 %
in 2012, in line with national estimates. Women were younger than men, fewer
reported a history of IDU (16.1 vs. 73.8 %, p < 0.001)
and more were tested for HIV because of a positive partner (25.5 vs.
4.0 %, p < 0.001). The
majority of women were in their reproductive age, had children, and were not
using contraceptives at the time of enrolment.
Conclusion
HIV-infected women in
Indonesia have specific characteristics that differ them from women in the
general population. Further research to elucidate the characteristics of women
exposed to HIV, their access to testing and care and sexual and reproductive
needs can help reduce transmission to women and children in the context of
concentrated HIV epidemic in Indonesia.
Below: a Proportion
of female adult patients entering HIV care at Hasan Sadikin Hospital between
2007 and 2012. b Proportion
of female new HIV cases reported to the Ministry of Health between 2008 and
2013 [21]. Unfilled bar Number
of women; striped bar Number
of men; dotted bar Total
number of new cases; Grey line %
of women. Left y-axis refers
to bar graphs. Right y-axis refers
toline graphs
Full article at: http://goo.gl/r0WESJ
By: Annisa Rahmalia,
Rudi Wisaksana, Hinta Meijerink, Agnes R. Indrati, Bachti Alisjahbana, Nel Roeleveld, Andre J. A. M. van der Ven, Marie Laga, and Reinout van Crevel
Rudi Wisaksana, Hinta Meijerink, Agnes R. Indrati, Bachti Alisjahbana, Nel Roeleveld, Andre J. A. M. van der Ven, Marie Laga, and Reinout van Crevel
Tuberculosis and
HIV Research Centre, Faculty of Medicine Universitas Padjadjaran, Jl. Dr.
Eijkman No. 38, Bandung, 40161 Indonesia
Department of
Internal Medicine, Radboud University Medical Centre, Nijmegen, The Netherlands
Department of
Internal Medicine, Faculty of Medicine Universitas Padjadjaran, Bandung,
Indonesia
Department of
Clinical Pathology, Faculty of Medicine Universitas Padjadjaran, Bandung,
Indonesia
Department for
Health Evidence, Radboud University Medical Centre, Nijmegen, The Netherlands
Department of
Paediatrics, Radboud University Medical Centre, Nijmegen, The Netherlands
Department of
Public Health, Institute of Tropical Medicine, Antwerp, Belgium
Annisa Rahmalia, Email: ln.cmuduobdar@ailamhaR.asinnA.
More at: https://twitter.com/hiv_insight
Monday, November 16, 2015
A Survey on HIV-Related Health-Seeking Behaviors among Transgender Individuals in Jakarta, Based on the Theory of Planned Behavior
Male-to-female transgender (waria) individuals are at high risk for HIV. This
study aims at mapping the psychological determinants of four HIV-related
health-seeking behaviors. This knowledge can be used to develop effective
interventions to prevent the spread of HIV/AIDS.
The study involved 209 waria from
five districts in Jakarta, selected with a cluster sampling procedure.
Cross-sectional data were gathered through structured interviews. The four
examined behaviors are, visiting sexually transmitted infections (STIs)
services regularly, adherence to STI treatment, taking an HIV test and picking
up the result of HIV test. For all four behaviors, specific measures of the
psychological determinants as defined by the Theory of Planned Behavior were
developed: attitudes, subjective norms and perceived behavioral control (PBC).
Logistic regression analyses were conducted with these three psychological
measures as independent variables and the behaviors as dependent variables.
Of the 209 waria, 20.6 %
had never visited STI services in the last 6 months, while 56.5 % had
visited the services once or twice, and 23 % had visited the service three
or more times. A HIV test had been taken by 90.4 % of the waria, and of
those, 64.6 % had picked up the results. About 85 % of the waria who did a HIV test had been tested for HIV one
or two times in the last 6 months and 10 % had been tested three to four
times. The variance in behaviors that was explained by the concepts defined in
the Theory of Planned Behavior ranged from 15 to 70 %; PBC was the most
powerful predictor. Furthermore, the results showed that in several cases the
relationships of attitudes or subjective norms with the dependent variable were
mediated by one or both other independent variables.
The results regarding the prominent role of PBC suggest that
interventions should increase waria’s control over the behavior: Engaging in
specific desired behaviors should be made easier for them. Besides, waria’s attitudes
and subjective norms should be addressed, by education, but possibly also by
providing waria with
a positive experience with the behavior, for example, by designing a
professional and friendly health care system.
Full article at: http://goo.gl/7X00Af
1Social Psychology Department, Faculty of
Behavioral and Social Sciences, University of Groningen, Grote Kruisstraat 2/1
9712 TS, Groningen, The Netherlands
2Population Studies and Biostatistic
Department, Faculty of Public Health, University of Indonesia, Kampus UI, Depok
16424, West Java, Indonesia
3Faculty of Psychology, University of
Indonesia, Kampus UI, Depok 16424, West Java, Indonesia
More at: https://twitter.com/hiv_insight
Thursday, November 12, 2015
Estimation of Cancer Burden Attributable to Infection in Asia
Some infectious agents have been shown to be human
carcinogens. The current study focused on estimation of cancer burden attributable
to infection in different regions of Asia.
By systematically reviewing previous studies of the
infection prevalence data of 13 countries in Asia and relative risks of
specific cancers, we calculated the population attributable fraction of
carcinogenic infections. Using data from GLOBOCAN 2012, the overall
country-specific and gender-specific number of new cancer cases and deaths
resulting from infection were estimated.
Across 13 principal Asian countries, the average prevalence
and range was 6.6% (0.5% in Japanese women to 15.0% in Vietnamese men) for
hepatitis B virus (HBV), 2.6% (0.3% in Iran to 5.1% in Saudi Arabia) for
hepatitis C virus (HCV), 7.9% (2.8% in Pakistan to 17.7% in China) for human
papillomavirus (HPV), and 61.8% (12.8% in Indonesia to 91.7% in Bangladesh) for Helicobacter pylori (HP).
The estimated total number of cancer cases and deaths caused by infection in
these 13 countries were 1 212 026 (19.6% of all new cancer cases) and 908 549
(22.0% of all deaths from cancer). The fractions of cancer incidence
attributable to infection were 19.7% and 19.5% in men and women, respectively.
The percentages of cancer deaths attributable to infection were 21.9% and 22.1%
in men and women, respectively. Among the main infectious agents, HP was
responsible for 31.5% of infection-related cancer cases and 32.8% of
infection-related cancer deaths, followed by HBV (28.6% of new cases and 23.8%
of deaths), HPV (22.0% of new cases and 27.3% of deaths), and HCV (12.2% of new
cases and 10.6% of deaths).
Approximately one quarter of all cancer cases and deaths
were infection-associated in Asia, which could be effectively prevented if
appropriate long-term controls of infectious agents were applied.
Below: Proportion of estimated new cancer cases and deaths attributable to different infectious agents in men and women
Full article at: http://goo.gl/HTZsxV
By: He Huang,1,2 Xiao-Feng Hu,3 Fang-Hui Zhao,1 Suzanne M. Garland,4 Neerja Bhatla,5 and You-Lin Qiao1
1Department of Cancer Epidemiology, Cancer
Institute, Chinese Academy of Medical Sciences & Peking Union Medical
College, Beijing, China
2Department of Prevention and Control of
Communicable Disease, Guizhou Center for Disease Control and Prevention, Guiyang,
Guizhou, China
3Shijingshan District Center for Disease
Control and Prevention, Beijing, China
4The Microbiology and Infectious Diseases
Department, Royal Women’s Hospital, and the Department of Obstetrics and
Gynecology, University of Melbourne, Melbourne, Australia
5Department of Obstetrics &
Gynaecology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi,
India
Address for correspondence. Fang-Hui Zhao, Department of
Cancer Epidemiology, Cancer Institute, Chinese Academy of Medical Sciences
& Peking Union Medical College, 17 South Panjiayuan Lane, P.O. Box 2258,
Beijing 100021, China (e-mail: nc.ca.smacic@hgnafoahz).
More at: https://twitter.com/hiv_insight
Wednesday, October 28, 2015
Somadril and Edgework in South Sulawesi
The use of psychoactive
prescription drugs (PPDs) by young people is part of a broader worldwide trend
towards the consumption of pharmaceuticals to improve social, emotional, and
sexual performance. Few studies have examined how young people use PPDs in
developing countries, where off-label use is likely to be greater due to weaker
market controls.
This study presents our findings on PPD use among sex workers
in Makassar, Indonesia. We focus on one potent painkiller, Somadril, which is
freely available over the counter in pharmacies. The sex workers we studied
used most of their earnings to purchase Somadril pills, which they used to feel
more confident and to make their work more palatable.
This paper also traces
the history of the active component in Somadril, carisoprodol. This was
developed in the United States, where it was soon used recreationally. We found
that knowledge of its effects seeped from health professionals into youth
networks, where it was spread by word of mouth. The flow of information on
carisoprodol's harmful effects, however, was less evident...
In Makassar's Losari Beach, the sex workers whom we
interviewed work freelance, finding customers through referrals from bellboys
and becak drivers. They live in a nocturnal peer group that
shares everything – food, lodging, and earnings from customers. They help each
other to find customers and then use the proceeds to buy food and drugs for
everybody. As we joined in their gatherings, especially on Wednesday and
Saturday evenings (the former is ladies’ night, the latter a popular evening
for young people to go out), it became clear to us that the priority in their
lives was Somadril. The sex workers in Makassar craved the drug. Whereas the
young women in Isidro got drunk on beer, sex workers in Makassar used Somadril
to get high.
The sex workers at Losari Beach consumed Somadril in
different ways. Some chewed it; others took it with Sprite (a soft drink
commonly used as a solvent for drugs in Indonesia). Others mixed it with red
label whiskey or Topi Roja, a local brand of vodka. As Rina told us: ‘If you mix
it with an alcoholic drink, the effect is sure to be great.’ Others mixed
Somadril with other PPDs such as Calmlet (alprazolam) or the painkiller
Tramadol. Hasan, reflecting on his mixing of Tramadol and Somadril, said it
made him ‘act like a mad man’. When they had enough money, they bought pedas (hot)
food, which they said makes them sweat and enhances the high. They also wore
warm jackets, and avoided the wind and cold drinks, which they said weakened
the effect of Somadril.
When they could not get enough Somadril, our informants
mixed or substituted it with cheaper PPDs such as ‘LL’ (also called ‘DoubleL’;
chemical content unknown), which was bought from street vendors in sachets of
around 10 pills and ‘Dextro’ (dextromethorphan, a cough medicine sold in
generic containers in pharmacies). To get high, they swallowed 20–30 Dextro or
several LL pills. Neither are very strong, they said. Mira was one of the sex
workers who kept a diary for us:
May 13 (2012): Last night I took only three pills of
Somadril. For me, only taking three pills gives me a bad headache, it feels
like my head will break into pieces.
May 14: I took five pills of Somad, and I added DoubleL,
and I felt like a fool. DoubleL makes us uncommunicative, and not friendly to
people. But, I like mixing Somad with DoubleL.
May 15: We didn’t have a supply of Somad, because we have
a debt with the seller. I took 15 pills of Dextro and added three pills of
DoubleL, and I felt like I had nothing … no worries, no debt, no sins…. But I
am worried that if I take too much, it won’t work. It will kill me.
May 16: I took five pills of Somad, and it gave me a
headache and I became sleepy…. Dextro makes me sweat like shabu-shabu
[methamphetamine], because the heat comes from inside [panas dalam]. It makes
me feel weak … but it can also make me feel confident if someone asks me for a
date.
May 17: I have taken 10 pills of DoubleL, because I am in
a bad mood, and I have nothing to do. DoubleL made me feel crazy, we laughed
about everything, even things that are not funny.
May 18: I have taken 9 pills of Somad and I also drank 2
bottles of beer, so it feels really good. It's balanced with beer. It makes me
sleepy, but I enjoy it because it makes me feel confident.
Dextro and LL are second-choice drugs among sex workers.
Dextro, our informants say, is used a lot among high school-aged young people
(below age 18, and not included in our study) who lack the money to buy more
expensive PPDs.
We were struck by the uniformity in the reported beneficial
effects of Somadril. All of the sex workers to whom we talked said using it
made them feel more pede (confident) and/or less malu (shy).
These are important qualities in attracting customers; the drug makes the sex
workers talkative and feel less inner resistance to their work. As Samsul notes
in his diary: ‘I took four pills of Somad and five pills of DoubleL because if
I am not taking Somad I have no confidence to accompany my clients, and no
desire to look for them.’ Another entry in his diary stresses the uselessness
of DoubleL for his work: ‘I didn’t have money to buy Somad, so finally a friend
gave me DoubleL, but my eyes blurred and I looked like a fool…. I just kept on
laughing, acting like a madman...
Full article
at: http://goo.gl/SGXX0n
By: Anita P. Hardon⁎ and Amelia Ihsan
Amsterdam
Institute for Social Science Research, Nieuwe Achtergracht 166, 1018 WV
Amsterdam, The Netherlands
Anita P. Hardon: ln.avu@nodraH.P.A
More at: https://twitter.com/hiv_insight
Subscribe to:
Posts (Atom)






